Skip to main content

letter

. 1985 Sep 14;291(6497):739. doi: 10.1136/bmj.291.6497.739-a

CSM Update: adverse drug reactions and the liver

G Lake-Bakaar, H A Cameron

PMCID: PMC1416630 PMID: 3929924

739

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Amoah A. G., Gould B. J., Parke D. V. Single-dose pharmacokinetics of perhexiline administered orally to humans. J Chromatogr. 1984 Feb 10;305(2):401–409. doi: 10.1016/s0378-4347(00)83354-x. [DOI] [PubMed] [Google Scholar]
Daneshmend T. K., Warnock D. W., Ene M. D., Johnson E. M., Parker G., Richardson M. D., Roberts C. J. Multiple dose pharmacokinetics of ketoconazole and their effects on antipyrine kinetics in man. J Antimicrob Chemother. 1983 Aug;12(2):185–188. doi: 10.1093/jac/12.2.185. [DOI] [PubMed] [Google Scholar]
Duarte P. A., Chow C. C., Simmons F., Ruskin J. Fatal hepatitis associated with ketoconazole therapy. Arch Intern Med. 1984 May;144(5):1069–1070. [PubMed] [Google Scholar]
Lewis J. H., Zimmerman H. J., Benson G. D., Ishak K. G. Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases. Gastroenterology. 1984 Mar;86(3):503–513. [PubMed] [Google Scholar]
Simon J. B., Manley P. N., Brien J. F., Armstrong P. W. Amiodarone hepatotoxicity simulating alcoholic liver disease. N Engl J Med. 1984 Jul 19;311(3):167–172. doi: 10.1056/NEJM198407193110308. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES